Ashiya Mona — SEC Form 4 filings
SEC reporting owner CIK 1794070. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-06-14 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 2 filings — 6,389,461 shares, $8,471,850 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 27 legs across 3 filings — 370,551 shares, $20,108,066 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 106,384 shares @ $54.29 ($5,775,587) in Disc Medicine, Inc., filed 2025-03-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | Director | 6 | 3 legs · 83,334 sh · $3,000,024 | 27 legs · 370,551 sh · $20,108,066 | 2 |
| Shattuck Labs, Inc. (STTK) | Director | 5 | 2 legs · 6,306,127 sh · $5,471,826 | — | 12 |
| Yarrow Bioscience, Inc. (YARW) | Director | 1 | — | — | 1 |
Form 4 filings — Ashiya Mona
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-29 | 4 | Yarrow Bioscience, Inc. (YARW) | Grant/award (A): 15,435 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Shattuck Labs, Inc. (STTK) | Purchase (P): 1,041,667 (derivative) · Purchase (P): 208,333 (derivative) | EDGAR |
| 2026-06-09 | 4 | Shattuck Labs, Inc. (STTK) | Conversion (C): 15,366,490 (derivative) · Conversion (C): 3,073,298 (derivative) · Conversion (C): 15,366,490 (derivative) · Conversion (C): 3,073,298 (derivative) | EDGAR |
| 2026-06-02 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 81,000 (derivative) @ $0 | EDGAR |
| 2025-09-02 | 4 | Shattuck Labs, Inc. (STTK) | Purchase (P): 5,255,106 @ $0.87 · Purchase (P): 1,051,021 @ $0.87 · Purchase (P): 10,111,384 (derivative) · Purchase (P): 2,022,277 (derivative) · Purchase (P): 15,366,490 (derivative) · Purchase (P): 3,073,298 (derivative) | EDGAR |
| 2025-09-02 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 66,300 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 1,956 @ $54.11 · Sale (S): 3,026 @ $54.11 · Sale (S): 756 @ $54.11 | EDGAR |
| 2025-03-21 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 13,517 @ $54.02 · Sale (S): 20,911 @ $54.02 · Sale (S): 5,228 @ $54.02 · Sale (S): 941 @ $54.01 · Sale (S): 1,457 @ $54.01 · Sale (S): 364 @ $54.01 · +3 more | EDGAR |
| 2025-03-12 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 68,766 @ $54.29 · Sale (S): 106,384 @ $54.29 · Sale (S): 26,596 @ $54.29 · Sale (S): 136 @ $55.01 · Sale (S): 211 @ $55.01 · Sale (S): 53 @ $55.01 · +9 more | EDGAR |
| 2024-06-20 | 4 | Disc Medicine, Inc. (IRON) | Purchase (P): 28,404 @ $36 · Purchase (P): 43,944 @ $36 · Purchase (P): 10,986 @ $36 | EDGAR |
| 2024-06-14 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1794070 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →